This content is restricted.
Brief
On November 25, 2024, the Securities and Exchange Board of India issued an update regarding Corrigendum to Order dated November 22, 2024 in the matter of insider trading in the scrip of Jagsonpal Pharmaceuticals Limited. The corrigendum corrects a typographical error in the original order, amending paragraph 57.1 to accurately reflect the restraints on Mr. Maneesh Kumar Jain and Mr. S.V. Subha Rao.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested